OptionsHouse

Options Trading News

November 7, 2011  Mon 7:26 AM CT

TKLC: SEE CHART GET CHAIN FIND STRATEGIES
Deal Values Tekelec at $780 Million

Tekelec, a maker of networking technology, agreed to be purchased by Siris Capital for $11 a share. TKLC pops 11 percent before the bell.

Pharmasset Lifted by Hep-C Data

Pharmasset released data over the weekend showing promise of its PSI-7977 compound in fighting Hepatitis C. Those results were from a Phase II trial, and now support the case for more advanced Phase III testing. VRUS climbs 9 percent in the premarket.

Omnivision Lowers Outlook

Omnivision Technologies cut its outlook in a preliminary earnings release because of an "unexpected cutback in orders." Management now sees revenue of now more than $217 million, down from an earlier $255-275 million estimate. OVTI drops 17 percent in the pre.
Share this article with your friends


OptionsHouse

Premium Services

Education & Strategy

Investor deficiency in premium collection

Most investors have heard about selling options as a form of income generation. You hear it from brokers and financial advisors as a way to generate income without selling off pieces of your nest egg, dwindling through your retirement accounts, and then being stuck figuring out how to financially afford the rest of your life...

View more education articles »